How long must a patient discontinue stimulant medication before undergoing a Multiple Sleep Latency Test (MSLT)?

Stimulant Medication Discontinuation Before MSLT

Patients must discontinue stimulant medications for at least 2 weeks (14-15 days) prior to undergoing a Multiple Sleep Latency Test (MSLT).

Medication Washout Period

The most recent AASM guidance on MSLT protocols 1 emphasizes that medications affecting sleep and wakefulness—including stimulants—must be discontinued with sufficient time for complete elimination before testing. While the 2021 protocol update doesn't specify exact washout periods for each medication class, the standard practice derived from clinical consensus and pharmacokinetic principles requires:

• Stimulant medications: 2 weeks minimum (14-15 days)
• This applies to all stimulants including methylphenidate, amphetamines, modafinil, armodafinil, and other wakefulness-promoting agents

The rationale is straightforward: stimulants directly suppress REM sleep and increase sleep latency, which would invalidate MSLT results by masking pathological sleepiness. Even after the drug is cleared from the bloodstream, residual effects on sleep architecture may persist for several days.

Pre-Test Sleep Monitoring

Concurrent with medication discontinuation, actigraphy should be used for 7-14 days prior to the PSG/MSLT to ensure adequate total sleep time 2. This monitoring period serves dual purposes:

• Confirms the patient is obtaining sufficient sleep (typically ≥6 hours per night)
• Documents that chronic sleep debt isn't confounding results, which can produce false-positive shortened sleep latencies 3

Critical Pitfalls to Avoid

Insufficient sleep debt resolution is a major source of false-positive MSLT results. Even one night of adequate sleep during the pre-MSLT PSG may not resolve chronic sleep debt 3. In one study, 5 of 12 patients with initially shortened sleep latencies (mean 5.8 minutes) normalized to 13.9 minutes after extended sleep opportunity, preventing misdiagnosis and inappropriate stimulant prescription.

Common errors include:

• Stopping stimulants for only 5-7 days (insufficient washout)
• Not monitoring sleep adequacy during the washout period
• Proceeding with MSLT when actigraphy shows inadequate sleep time
• Failing to extend hospitalization when chronic sleep debt is suspected

Clinical Algorithm

1. Discontinue stimulants 14-15 days before scheduled MSLT
2. Begin actigraphy monitoring simultaneously (minimum 7 days, preferably 14 days)
3. Review actigraphy data to confirm adequate total sleep time
4. If sleep debt suspected: Extend hospitalization or reschedule MSLT with additional recovery sleep nights
5. Perform overnight PSG followed by MSLT the next day

The 2021 AASM protocol 1 represents consensus-based guidance when direct evidence is limited, but the principle is clear: any medication that affects sleep-wake regulation must be fully cleared before objective sleepiness testing to ensure diagnostic accuracy and prevent inappropriate treatment decisions.